Therapeutic strategies for DMD include antisense therapies restoring dystrophin function, modulation of fibrosis-related genes such as Col6a1 and Mmp2, and targeting signaling pathways like PI3K/AKT to enhance muscle regeneration and function. This evidence concerns the gene COL6A1 and Duchenne muscular dystrophy.